Uma Mahadevan, MD
Professor
Medicine
School of Medicine

Lynne and Marc Benioff Professor of Gastroenterology University of California, San Francisco Director, UCSF Center for Colitis and Crohn's Disease Website: IBD.UCSF.EDU Twitter: @UmaMahadevanIBD

Dr. Uma Mahadevan is the Lynne and Marc Benioff Professor of Gastroenterology, Director of the Colitis and Crohn's Disease Center and Director of the Advanced IBD Fellowship at the University of California, San Francisco. She specializes in inflammatory bowel disease (IBD), particularly pregnancy and drug safety. She completed a medical degree at the State University of New York in Brooklyn, residency in internal medicine at Mount Sinai Medical Center in New York, Fellowship in gastroenterology at UCSF, and Advanced fellowship in IBD at the Mayo Clinic, Rochester, Minnesota. For her exceptional work in pregnancy and drug safety and her mentoring of GI fellows and junior faculty she received the AGA 2022 Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section Research Mentor Award and the 2022 Sherman Prize. Dr. Mahadevan is a fellow of the American Gastroenterological Association, for whom she was Chair for the IMIBD Section, Chair of the AGA National IBD Parenthood initiative and Director (2023) and co-Director (2022, 2017) of the AGA Postgraduate Course. She is a Fellow of the American College of Gastroenterology and served on the Educational Affairs Committee and as a member of the Advanced IBD Fellow Curriculum Committee. She was Chair of the Crohns Colitis Foundation Clinical Research Grants committee, a member of the National Scientific Advisory Committee and Taskforce on Women in IBD, and co-chair of the annual Crohn’s Colitis Congress (2020). Dr. Mahadevan is a member of the International Organization of IBD (IOIBD) for which she serves on the nominating committee. Dr. Mahadevan has served on many prestigious journals, including special section editor for Gastroenterology. Dr. Mahadevan has published over 100 original articles, abstracts, editorials, and invited reviews in such peer-reviewed journals as Gastroenterology, Gut, Nature Reviews, American Journal of Gastroenterology, Inflammatory Bowel Diseases, and Lancet Gastroenterology Hepatology as well as several book chapters. She authored the joint AGA, Society of Maternal Fetal Medicine Clinical Care Pathway on the Management of IBD in Pregnancy. Dr. Mahadevan is a global expert on the management of pregnancy and drug safety in the patient with IBD. She is also interested in the role of diet and IBD and has an ongoing original study in this area. Her current projects include a national prospective registry of pregnancy outcomes and drug safety in women with IBD on immunosuppressive and biologic medications (PIANO) and a clinical trial on the impact of nutritional interventions in the management of IBD (SEAMUS). She has an interest in digital health and lead the transition of the GI Division to telemedicine at the start of the pandemic in March 2020 and has developed an IBD Chatbot with the Center for Digital Health and Innovation at UCSF. Dr. Mahadevan is proud to have mentored several Advanced IBD Fellows who know hold key roles in IBD Centers around the United States.

• Single-cell and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitis.
  Nature communications 2024 Mennillo E, Kim YJ, Lee G, Rusu I, Patel RK, Dorman LC, Flynn E, Li S, Bain JL, Andersen C, Rao A, Tamaki S, Tsui J, Shen A, Lotstein ML, Rahim M, Naser M, Bernard-Vazquez F, Eckalbar W, Cho SJ, Beck …
• Tofacitinib in Pregnancy: Assessing Pregnancy and Infant Outcomes, Cord Blood, and Breast Milk Concentrations.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024 Mitrova K, Julsgaard M, Augustijns P, Cerna K, Mahadevan U, Duricova D, Pregnancy Study Group
• Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn's Disease, and Relapsing Multiple Sclerosis.
  Inflammatory bowel diseases 2024 Dubinsky MC, Charles L, Selmaj KW, Comi G, Krakovich A, Rosen M, van der Woude CJ, Mahadevan U
• Assessing the Impact of COVID-19 on IBD Outcomes Among Vulnerable Patient Populations in a Large Metropolitan Center.
  Inflammatory bowel diseases 2024 Odufalu FD, Sewell JL, Rudrapatna V, Somsouk M, Mahadevan U
• Single-cell and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitis.
  bioRxiv : the preprint server for biology 2024 Mennillo E, Kim YJ, Lee G, Rusu I, Patel RK, Dorman LC, Flynn E, Li S, Bain JL, Andersen C, Rao A, Tamaki S, Tsui J, Shen A, Lotstein ML, Rahim M, Naser M, Bernard-Vazquez F, Eckalbar W, Cho SJ, Beck …
• Inflammatory Bowel Disease and the Risk of Anal Squamous Intraepithelial Lesions and Anal Cancer in Men Who Have Sex With Men.
  Inflammatory bowel diseases 2023 Field J, Fenton C, Zhang L, Brickman C, Mahadevan U
• A Digital Health Intervention to Improve the Clinical Care of Inflammatory Bowel Disease Patients.
  Applied clinical informatics 2023 Chugh R, Liu AW, Idomsky Y, Bigazzi O, Maiorano A, Medina E, Pierce L, Odisho AY, Mahadevan U
• Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis.
  The lancet. Gastroenterology & hepatology 2023 Julsgaard M, Mahadevan U, Vestergaard T, Mols R, Ferrante M, Augustijns P
• Real-World Experience With Tofacitinib Dose De-Escalation in Patients With Moderate and Severe Ulcerative Colitis.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2023 Yu A, Ha NB, Shi B, Cheng YW, Mahadevan U, Beck KR
• Multicentre Real-world Experience of Upadacitinib in the Treatment of Crohn's Disease.
  Journal of Crohn's & colitis 2023 Chugh R, Braga-Neto MB, Fredrick TW, Ramos GP, Terdiman J, El-Nachef N, Loftus EV, Mahadevan U, Kane SV
• Creation of an ustekinumab external control arm for Crohn's disease using electronic health records data: A pilot study.
  PloS one 2023 Rudrapatna VA, Cheng YW, Feuille C, Mosenia A, Shih J, Shi Y, Roberson O, Rubin B, Butte AJ, Mahadevan U, Skomrock N, Erondu N, Chehoud C, Rahim S, Apfel D, Curran M, Khan NS, O'Brien C, Terry N, …
• Tips and Tricks: Starting Your Own Continuing Medical Education Course.
  Gastroenterology 2023 Hansel S, Muthusamy VR, Mahadevan U
• Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022 Singh S, Kim J, Luo J, Paul P, Rudrapatna V, Park S, Zheng K, Syal G, Ha C, Fleshner P, McGovern D, Sauk JS, Limketkai B, Dulai PS, Boland BS, Eisenstein S, Ramamoorthy S, Melmed G, Mahadevan U, …
• Vedolizumab Antagonizes MAdCAM-1-Dependent Human Placental Cytotrophoblast Adhesion and Invasion In Vitro.
  Inflammatory bowel diseases 2022 Blaisdell A, Zhou Y, Kattah MG, Fisher SJ, Mahadevan U
• Advanced Fellowship Training in IBD: A Worthwhile Fourth Year.
  Digestive diseases and sciences 2022 Chugh R, Mahadevan U
• Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
  The American journal of gastroenterology 2022 Gu P, Luo J, Kim J, Paul P, Limketkai B, Sauk JS, Park S, Parekh N, Zheng K, Rudrapatna V, Syal G, Ha C, McGovern DP, Melmed GY, Fleshner P, Eisenstein S, Ramamoorthy S, Dulai PS, Boland BS, Grunvald …
• Closing the gender gap: building a successful career and leadership in research as a female gastroenterologist.
  The lancet. Gastroenterology & hepatology 2022 Mahadevan U, Abraham NS, Lennon AM, Charabaty A, Vermeire S
• Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022 Nguyen NH, Luo J, Paul P, Kim J, Syal G, Ha C, Rudrapatna V, Park S, Parekh N, Zheng K, Sauk JS, Limketkai B, Fleshner P, Eisenstein S, Ramamoorthy S, Melmed G, Dulai PS, Boland BS, Mahadevan U, …
• Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer's global safety database.
  Alimentary pharmacology & therapeutics 2022 Mahadevan U, Naureckas S, Tikhonov I, Wang Y, Lin CB, Geldhof A, van der Woude CJ
• Delayed Initiation of Rescue Therapy Associated with Increased Length of Stay in Acute Severe Ulcerative Colitis.
  Digestive diseases and sciences 2022 Caplan A, McConnell R, Velayos F, Mahadevan U, Lewin S
• Performing surveillance endoscopy for patients with inflammatory bowel disease.
  Gastrointestinal endoscopy 2022 Mahadevan U
• Women's Willingness to Accept Risks of Medication for Inflammatory Bowel Disease During Pregnancy.
  The patient 2021 Kushner T, Fairchild A, Johnson FR, Sands BE, Mahadevan U, Subramanian S, Ananthakrishnan A, Ha C, Bewtra M
• Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry.
  Gut 2021 Odufalu FD, Long M, Lin K, Mahadevan U, PIANO Investigators from the Crohn’s and Colitis Foundation (CCF) Clinical Research Alliance recruit
• Cutaneous Chaetomium globosum Infection in a Vedolizumab-Treated Patient.
  Cutis 2021 Cronin M, Berger TG, Cohen SH, Mahadevan U, North JP, Asch S
• The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Ulcerative Colitis.
  Diseases of the colon and rectum 2021 Holubar SD, Lightner AL, Poylin V, Vogel JD, Gaertner W, Davis B, Davis KG, Mahadevan U, Shah SA, Kane SV, Steele SR, Paquette IM, Feingold DL, Prepared on behalf of the Clinical Practice Guidelines …
• The Impact of Introducing Patient-Reported Inflammatory Bowel Disease Symptoms via Electronic Survey on Clinic Visit Length, Patient and Provider Satisfaction, and the Environment Microbiome.
  Inflammatory bowel diseases 2021 Roy Paladhi U, Harb AH, Daniel SG, Dawwas GK, Schnellinger EM, Wollack C, Aberra FN, Bewtra M, Green JA, Klaproth JA, Lichtenstein GR, Saxena A, Berera S, Buchner A, Mehta SJ, Osterman MT, Rashid F, …
• Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases.
  Gastroenterology 2021 Meserve J, Luo J, Zhu W, Veeravalli N, Bandoli G, Chambers CD, Singh AG, Boland BS, Sandborn WJ, Mahadevan U, Singh S
• Day Care Attendance and Infectious Complications in Children Born to Mothers With Inflammatory Bowel Disease.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021 Long MD, Siegel CA, Abraham BP, Chiorean M, Mahadevan U
• Overview of Pregnancy in Patients With Inflammatory Bowel Disease.
  Gastroenterology & hepatology 2021 Mahadevan U
• Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease.
  Gastroenterology 2020 Mahadevan U, Long MD, Kane SV, Roy A, Dubinsky MC, Sands BE, Cohen RD, Chambers CD, Sandborn WJ, Crohn’s Colitis Foundation Clinical Research Alliance
• International Organization for the Study of Inflammatory Bowel Disease: Global Strategies for Telemedicine and Inflammatory Bowel Diseases.
  Journal of Crohn's & colitis 2020 Lewin S, Lees C, Regueiro M, Hart A, Mahadevan U
• Treat-to-target approach in the management of inflammatory Bowel disease.
  Gastroenterologia y hepatologia 2020 Nuñez F P, Mahadevan U, Quera R, Bay C, Ibañez P
• Importance of Not MSing Cerebral White Matter Disease in Patients with Inflammatory Bowel Disease.
  Digestive diseases and sciences 2020 Regner EH, Green AJ, Bain JL, Kattah MG, Mahadevan U
• Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States.
  Inflammatory bowel diseases 2020 Cohen BL, Gallinger ZR, Ha C, Holubar SD, Hou JK, Kinnucan J, Mahadevan U, Moss AC, Raffals LE, Regueiro M, Szigethy E, Wolf D, Dubinsky MC, Patel A, Shah BJ, Ehrlich OG, Hanauer SB
• The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn's Disease.
  Diseases of the colon and rectum 2020 Lightner AL, Vogel JD, Carmichael JC, Keller DS, Shah SA, Mahadevan U, Kane SV, Paquette IM, Steele SR, Feingold DL
• Innovation in Inflammatory Bowel Disease Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease.
  Gastroenterology 2020 Lees CW, Regueiro M, Mahadevan U, International Organization for the Study of Inflammatory Bowel Disease
• Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases.
  Neurology(R) neuroimmunology & neuroinflammation 2020 LaHue SC, Anderson A, Krysko KM, Rutatangwa A, Dorsey MJ, Hale T, Mahadevan U, Rogers EE, Rosenstein MG, Bove R
• Men With Inflammatory Bowel Disease: Sexual Function, Fertility, Medication Safety, and Prostate Cancer.
  The American journal of gastroenterology 2020 Hammami MB, Mahadevan U
• Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020 Levine A, Rhodes JM, Lindsay JO, Abreu MT, Kamm MA, Gibson PR, Gasche C, Silverberg MS, Mahadevan U, Boneh RS, Wine E, Damas OM, Syme G, Trakman GL, Yao CK, Stockhamer S, Hammami MB, Garces LC, Rogler…
• Safety of Flexible Sigmoidoscopy in Pregnant Patients with Known or Suspected Inflammatory Bowel Disease.
  Digestive diseases and sciences 2020 Ko MS, Rudrapatna VA, Avila P, Mahadevan U
• Infliximab Use in a Child With Ulcerative Colitis and Prior In Utero Exposure to Infliximab.
  Gastroenterology 2020 Lim J, Hammami MB, Mahadevan U
• Erratum: Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group.
  Inflammatory bowel diseases 2019 Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, Friedman S, Kane S, Manthey J, Sauberan J, Stone J, Jain R
• Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol.
  Inflammatory bowel diseases 2019 Lewin SM, McConnell RA, Patel R, Sharpton SR, Velayos F, Mahadevan U
• Reply.
  Gastroenterology 2019 Mahadevan U, Fisher S, Riley L, Chambers C, Jain R, Robinson C, co-authors of the AGA Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway
• Challenges in IBD Research: Pragmatic Clinical Research.
  Inflammatory bowel diseases 2019 Scott FI, Rubin DT, Kugathasan S, Bousvaros A, Elson CO, Newberry RD, Melmed GY, Pekow J, Fleshman JW, Boyle BM, Mahadevan U, Cannon LM, Long MD, Cross RK, Ha CY, Lasch KL, Robinson AM, Rafferty JF, …
• Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group.
  American journal of obstetrics and gynecology 2019 Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, Friedman S, Kane S, Manthey J, Sauberan J, Stone J, Jain R
• Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group.
  Inflammatory bowel diseases 2019 Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, Friedman S, Kane S, Manthey J, Sauberan J, Stone J, Jain R
• Preventive Health Care Among Postpartum Women With Inflammatory Bowel Disease: Results From the PIANO Registry.
  Inflammatory bowel diseases 2019 Mao EJ, Sheibani S, Martin C, Bloomfeld RS, Isaacs K, Saha S, Mahadevan U
• Balancing the Checkpoint: Managing Colitis Associated with Dual Checkpoint Inhibitors and High-Dose Aspirin.
  Digestive diseases and sciences 2019 Hammami MB, Gill R, Thiruvengadam N, Oh DY, Beck K, Mahadevan U, Kattah MG
• Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group.
  Gastroenterology 2019 Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, Friedman S, Kane S, Manthey J, Sauberan J, Stone J, Jain R
• How Dye May Prevent Dying from Cancer: Perceiving Imperceptible Dysplasia in Inflammatory Bowel Disease.
  Digestive diseases and sciences 2019 Lewin SM, Wen KW, Velayos FS, Mahadevan U, Beck KR
• Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis.
  Inflammatory bowel diseases 2018 Mahadevan U, Dubinsky MC, Su C, Lawendy N, Jones TV, Marren A, Zhang H, Graham D, Clowse MEB, Feldman SR, Baumgart DC
• The Debate is Over: Continue Anti-Tumor Necrosis Factor Therapy Throughout Pregnancy.
  The American journal of gastroenterology 2018 Mao EJ, Mahadevan U
• Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease-authors' reply.
  Alimentary pharmacology & therapeutics 2018 Mahadevan U, Vermeire S, Lasch K, Abhyankar B, Bhayat F, Blake A, Dubinsky M
• Correction: Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants.
  Clinical and translational gastroenterology 2018 Kattah MG, Milush JM, Burt T, McCabe RP, Whang MI, Ma A, Mahadevan U
• Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report.
  The American journal of gastroenterology 2018 Lichtenstein GR, Feagan BG, Mahadevan U, Salzberg BA, Langholff W, Morgan JG, Safdi M, Nissinen R, Taillard F, Sandborn WJ, Cohen RD
• Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.
  Gastroenterology 2018 Matro R, Martin CF, Wolf D, Shah SA, Mahadevan U
• Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants.
  Clinical and translational gastroenterology 2018 Kattah MG, Milush JM, Burt T, McCabe RP, Whang MI, Ma A, Mahadevan U
• Inflammatory Bowel Disease-Gastroenterology Diamond Jubilee Review.
  Gastroenterology 2018 Mahadevan U, Silverberg MS
• Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017 Beaulieu DB, Ananthakrishnan AN, Martin C, Cohen RD, Kane SV, Mahadevan U
• Inadequate Gestational Weight Gain, the Hidden Link Between Maternal IBD and Adverse Pregnancy Outcomes: Results from the Norwegian Mother and Child Cohort Study.
  Inflammatory bowel diseases 2017 Bengtson MB, Aamodt G, Mahadevan U, Vatn MH
• Editorial: vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum? Authors' reply.
  Alimentary pharmacology & therapeutics 2017 Mahadevan U, Vermeire S, Lasch K, Abhyankar B, Bhayat F, Blake A, Dubinsky M
• How to Get an Education in Inflammatory Bowel Disease During Fellowship: Expectations and Realities.
  Gastroenterology 2017 Mahadevan U
• Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort.
  Digestive diseases and sciences 2017 Bengtson MB, Martin CF, Aamodt G, Vatn MH, Mahadevan U
• Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease.
  Alimentary pharmacology & therapeutics 2017 Mahadevan U, Vermeire S, Lasch K, Abhyankar B, Bhayat F, Blake A, Dubinsky M
• Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease.
  Gastroenterology 2016 Mahadevan U, McConnell RA, Chambers CD
• Disease Severity and Immune Activity Relate to Distinct Interkingdom Gut Microbiome States in Ethnically Distinct Ulcerative Colitis Patients.
  mBio 2016 Mar JS, LaMere BJ, Lin DL, Levan S, Nazareth M, Mahadevan U, Lynch SV
• The Birds, the Bees, and Inflammatory Bowel Disease: Preconception Care in Inflammatory Bowel Disease.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2016 McConnell RA, Mahadevan U
• A Novel Decision Aid for Surgical Patients with Ulcerative Colitis: Results of a Pilot Study.
  Diseases of the colon and rectum 2016 Cohan JN, Ozanne EM, Sewell JL, Hofer RK, Mahadevan U, Varma MG, Finlayson E
• Pregnancy and the Patient with Inflammatory Bowel Disease: Fertility, Treatment, Delivery, and Complications.
  Gastroenterology clinics of North America 2016 McConnell RA, Mahadevan U
• Detectable Drug Levels in Infants Exposed to Biologics: So What?
  Gastroenterology 2016 Kathpalia P, Kane S, Mahadevan U
• Vertical Transmission of Histoplasmosis Associated With Anti-Tumor Necrosis Factor Therapy.
  Journal of the Pediatric Infectious Diseases Society 2016 Carlucci JG, Halasa N, Creech CB, Dulek DE, Gómez-Duarte OG, Nelson GE, Talbot HK, Scalise ML, Scott PL, Mahadevan U, Beaulieu DB
• The Effect of Maternal Peripartum Anti-TNFα Use on Infant Immune Response.
  Digestive diseases and sciences 2016 Sheibani S, Cohen R, Kane S, Dubinsky M, Church JA, Mahadevan U
• Use of Immunomodulators and Biologics Before, During, and After Pregnancy.
  Inflammatory bowel diseases 2016 McConnell RA, Mahadevan U
• The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy.
  Gastroenterology 2015 Nguyen GC, Seow CH, Maxwell C, Huang V, Leung Y, Jones J, Leontiadis GI, Tse F, Mahadevan U, van der Woude CJ, IBD in Pregnancy Consensus Group, Canadian Association of Gastroenterology
• In Reply.
  Obstetrics and gynecology 2015 Mahadevan U, Matro R
• Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol.
  The Journal of rheumatology 2015 Clowse ME, Wolf DC, Förger F, Cush JJ, Golembesky A, Shaughnessy L, De Cuyper D, Mahadevan U
• Care of the Pregnant Patient With Inflammatory Bowel Disease.
  Obstetrics and gynecology 2015 Mahadevan U, Matro R
• Confocal laser endomicroscopy for membrane-bound tumor necrosis factor predicts response to therapy in Crohn's disease.
  Gastroenterology 2015 Kattah MG, Mahadevan U
• Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases.
  Arthritis care & research 2015 Kavanaugh A, Cush JJ, Ahmed MS, Bermas BL, Chakravarty E, Chambers C, Clowse M, Curtis JR, Dao K, Hankins GD, Koren G, Kim SC, Lapteva L, Mahadevan U, Moore T, Nolan M, Ren Z, Sammaritano LR, Seymour …
• Editorial: the management of IBD during pregnancy and lactation.
  Alimentary pharmacology & therapeutics 2014 Matro R, Mahadevan U
• A measured approach to Crohn's therapy: check levels and save.
  Gastroenterology 2014 Huang VW, Mahadevan U
• Pharmacokinetics of biologics and the role of therapeutic monitoring.
  Gastroenterology clinics of North America 2014 Lin K, Mahadevan U
• Insights into the molecular pathophysiology of inflammatory bowel disease: ATG16L1 suppresses nod-driven inflammation.
  Gastroenterology 2014 Kattah MG, Mahadevan U
• The use of biologic therapy in pregnancy: a gastroenterologist's perspective.
  Current opinion in rheumatology 2014 Hassid B, Mahadevan U
• Popular exclusionary diets for inflammatory bowel disease: the search for a dietary culprit.
  Inflammatory bowel diseases 2014 Hwang C, Ross V, Mahadevan U
• Immunoglobulin therapy for refractory Crohn's disease.
  Therapeutic advances in gastroenterology 2014 Shah S, Terdiman J, Gundling K, Mahadevan U
• My treatment approach to management of the pregnant patient with inflammatory bowel disease.
  Mayo Clinic proceedings 2014 Ng SW, Mahadevan U
• Etrolizumab: anti-β7-a novel therapy for ulcerative colitis.
  Gastroenterology 2013 Lin KK, Mahadevan U
• Serologic markers associated with development of Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis.
  Digestive diseases and sciences 2013 Truta B, Li DX, Mahadevan U, Fisher ER, Chen YY, Grace K, Velayos F, Terdiman JP
• Editorial: Are thiopurines and anti-TNFα agents safe to use in pregnant patients with inflammatory bowel disease?
  The American journal of gastroenterology 2013 Sheibani S, Mahadevan U
• Management of inflammatory bowel disease in pregnancy.
  Expert review of clinical immunology 2013 Ng SW, Mahadevan U
• Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease.
  Inflammatory bowel diseases 2013 Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS
• Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2012 Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, Ullman T, Glover S, Valentine JF, Rubin DT, Miller J, Abreu MT
• Cytokine profiles in peripheral blood of children and adults with Crohn disease.
  Journal of pediatric gastroenterology and nutrition 2012 Pak S, Holland N, Garnett EA, Mileti E, Mahadevan U, Beckert R, Kanwar B, Heyman MB
• Micronutrient deficiencies in inflammatory bowel disease: from A to zinc.
  Inflammatory bowel diseases 2012 Hwang C, Ross V, Mahadevan U
• Efficacy of anti-TNF therapies in refractory severe microscopic colitis.
  Journal of Crohn's & colitis 2011 Esteve M, Mahadevan U, Sainz E, Rodriguez E, Salas A, Fernández-Bañares F
• Transitioning the adolescent inflammatory bowel disease patient: guidelines for the adult and pediatric gastroenterologist.
  Inflammatory bowel diseases 2010 Leung Y, Heyman MB, Mahadevan U
• The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics.
  The American journal of gastroenterology 2010 Mahadevan U, Cucchiara S, Hyams JS, Steinwurz F, Nuti F, Travis SP, Sandborn WJ, Colombel JF
• IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient.
  Science translational medicine 2010 Broadhurst MJ, Leung JM, Kashyap V, McCune JM, Mahadevan U, McKerrow JH, Loke P
• European evidenced-based consensus on reproduction in inflammatory bowel disease.
  Journal of Crohn's & colitis 2010 van der Woude CJ, Kolacek S, Dotan I, Oresland T, Vermeire S, Munkholm P, Mahadevan U, Mackillop L, Dignass A, European Crohn's Colitis Organisation (ECCO)
• Inflammatory bowel disease and pregnancy: an update.
  Expert review of clinical immunology 2010 Kwan LY, Mahadevan U
• A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease.
  Gut 2010 Dotan I, Rachmilewitz D, Schreiber S, Eliakim R, van der Woude CJ, Kornbluth A, Buchman AL, Bar-Meir S, Bokemeyer B, Goldin E, Maaser C, Mahadevan U, Seidler U, Hoffman JC, Homoky D, Plasse T, Powers …
• Viral hepatitis and inflammatory bowel disease.
  Inflammatory bowel diseases 2010 Hou JK, Velayos F, Terrault N, Mahadevan U
• Anti-tumor necrosis factor therapy for inflammatory bowel disease in the setting of immunosuppression for solid organ transplantation.
  The American journal of gastroenterology 2010 El-Nachef N, Terdiman J, Mahadevan U
• Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis.
  Inflammatory bowel diseases 2010 Baumgart DC, Targan SR, Dignass AU, Mayer L, van Assche G, Hommes DW, Hanauer SB, Mahadevan U, Reinisch W, Plevy SE, Salzberg BA, Buchman AL, Mechkov GM, Krastev ZA, Lowder JN, Frankel MB, Sandborn WJ
• Do side-by-side anastomoses decrease the risk of recurrence in Crohn's disease?
  Gastroenterology 2010 Molloy JW, Kim E, Mahadevan U
• Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.
  Gastroenterology 2010 Sandborn WJ, Korzenik J, Lashner B, Leighton JA, Mahadevan U, Marion JF, Safdi M, Sninsky CA, Patel RM, Friedenberg KA, Dunnmon P, Ramsey D, Kane S
• Pregnancy and inflammatory bowel disease.
  The Medical clinics of North America 2010 Mahadevan U
• Use of infliximab in pregnancy.
  The American journal of gastroenterology 2010 Mahadevan U, Kane S
• Pregnancy and inflammatory bowel disease.
  Gastroenterology clinics of North America 2009 Mahadevan U
• Of blemishes and bowels: isotretinoin and inflammatory bowel disease.
  Gastroenterology 2009 Sewell JL, Mahadevan U
• Cervical neoplasia risk in IBD: truth or hysteria?
  Inflammatory bowel diseases 2009 Mahadevan U
• General health maintenance in IBD.
  Inflammatory bowel diseases 2009 Moscandrew M, Mahadevan U, Kane S
• An obscure harbinger. Difficult diagnosis of Crohn's Disease.
  The American journal of medicine 2009 McCabe JM, Mahadevan U, Vidyarthi A
• A new answer to an old question: azathioprine withdrawal in quiescent Crohn's disease.
  Gastroenterology 2009 Sewell JL, Mahadevan U
• A 24-year-old pregnant woman with inflammatory bowel disease.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009 Hou JK, Mahadevan U
• Angiographic embolization for control of life-threatening hemorrhage from benign rectal ulcers.
  Journal of vascular and interventional radiology : JVIR 2009 Costouros NG, Niho H, Mahadevan U, Kerlan RK, Bloom AI
• Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study.
  Inflammatory bowel diseases 2009 Thia KT, Mahadevan U, Feagan BG, Wong C, Cockeram A, Bitton A, Bernstein CN, Sandborn WJ
• Infliximab and surgical complications: truth or perception?
  Gastroenterology 2008 Sewell JL, Mahadevan U
• Management of the pregnant IBD patient.
  Inflammatory bowel diseases 2008 Dubinsky M, Abraham B, Mahadevan U
• Continuing immunomodulators and biologic medications in pregnant IBD patients - pro.
  Inflammatory bowel diseases 2007 Mahadevan U
• A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis.
  Gastroenterology 2007 Plevy S, Salzberg B, Van Assche G, Regueiro M, Hommes D, Sandborn W, Hanauer S, Targan S, Mayer L, Mahadevan U, Frankel M, Lowder J
• Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California.
  Gastroenterology 2007 Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA
• Management of steroid-dependent ulcerative colitis: immunomodulatory agents, biologics, or surgery?
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007 Velayos F, Mahadevan U
• Gastrointestinal medications in pregnancy.
  Best practice & research. Clinical gastroenterology 2007 Mahadevan U
• TNF-alpha antagonists: benefits beyond remission.
  Reviews in gastroenterological disorders 2007 Mahadevan U
• Fertility and pregnancy in the patient with inflammatory bowel disease.
  Gut 2006 Mahadevan U
• American gastroenterological association institute medical position statement on the use of gastrointestinal medications in pregnancy.
  Gastroenterology 2006 Mahadevan U, Kane S
• American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy.
  Gastroenterology 2006 Mahadevan U, Kane S
• Pregnancy, Fertility, and Therapies for IBD.
  Gastroenterology & hepatology 2006 Mahadevan U
• Mucosal healing in Crohn's disease: what you see is what you get?
  Gastrointestinal endoscopy 2006 Mahadevan U
• Adalimumab use in pregnancy.
  Gut 2005 Vesga L, Terdiman JP, Mahadevan U
• Infliximab and semen quality in men with inflammatory bowel disease.
  Inflammatory bowel diseases 2005 Mahadevan U, Terdiman JP, Aron J, Jacobsohn S, Turek P
• Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease.
  Alimentary pharmacology & therapeutics 2005 Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K, Terdiman JP, Binion DG
• Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease.
  Inflammatory bowel diseases 2005 Gill KR, Mahadevan U
• Medical treatment of ulcerative colitis.
  Clinics in colon and rectal surgery 2004 Mahadevan U
• Fistula response to methotrexate in Crohn's disease: a case series.
  Alimentary pharmacology & therapeutics 2003 Mahadevan U, Marion JF, Present DH
• 6TG: when less is more than you bargained for.
  Inflammatory bowel diseases 2003 Mahadevan U
• Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis.
  Inflammatory bowel diseases 2003 Mathy C, Schneider K, Chen YY, Varma M, Terdiman JP, Mahadevan U
• Diagnosis and management of pouchitis.
  Gastroenterology 2003 Mahadevan U, Sandborn WJ
• Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications.
  Inflammatory bowel diseases 2002 Mahadevan U, Loftus EV, Tremaine WJ, Pemberton JH, Harmsen WS, Schleck CD, Zinsmeister AR, Sandborn WJ
• Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease.
  The American journal of gastroenterology 2002 Mahadevan U, Loftus EV, Tremaine WJ, Sandborn WJ
• Evolving medical therapies for Crohn's disease.
  Current gastroenterology reports 2001 Mahadevan U, Sandborn WJ
• Infliximab for the treatment of orofacial Crohn's disease.
  Inflammatory bowel diseases 2001 Mahadevan U, Sandborn WJ
• Intravenous azathioprine in severe ulcerative colitis: a pilot study.
  The American journal of gastroenterology 2000 Mahadevan U, Tremaine WJ, Johnson T, Pike MG, Mays DC, Lipsky JJ, Sandborn WJ